Petros Pharmaceuticals, Inc.
Pharmaceutical company · New York, United States · OTC: PTPI
Petros Pharmaceuticals, Inc. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2020. Its shares trade on OTC under the ticker PTPI. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2023.
Petros Pharmaceuticals at a glance
What does Petros Pharmaceuticals do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $30 million sold (2023).
Frequently asked questions about Petros Pharmaceuticals
Where is Petros Pharmaceuticals headquartered?
Petros Pharmaceuticals, Inc. is headquartered in New York, United States.
What does Petros Pharmaceuticals do?
Petros Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Petros Pharmaceuticals a public company?
Yes. Petros Pharmaceuticals, Inc. trades on OTC under the ticker PTPI.
When was Petros Pharmaceuticals founded?
The earliest incorporation on record for Petros Pharmaceuticals, Inc. is in 2020, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences